Taccone FS, Artigas AA, Sprung CL, Moreno R, Sakr Y, Vincent J-L (2009) Characteristics and outcomes of cancer patients in European ICUs. Crit Care 13(1):R15
Article PubMed PubMed Central Google Scholar
Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy. Br Med J (Clin Res Ed) 296(6628):1025–1029
Article CAS PubMed Google Scholar
Manjappachar NK, Cuenca JA, Ramírez CM, Hernandez M, Martin P, Reyes MP et al (2022) Outcomes and predictors of 28-day mortality in patients with hematologic malignancies and septic shock defined by sepsis-3 criteria. J Natl Compr Canc Netw 20(1):45–53
Buchman TG, Simpson SQ, Sciarretta KL, Finne KP, Sowers N, Collier M et al (2020) Sepsis among medicare beneficiaries: 1. The burdens of sepsis, 2012-2018. Crit Care Med 48(3):276–88
Article PubMed PubMed Central Google Scholar
Hawari FI, Nazer LH, Addassi A, Rimawi D, Jamal K (2016) Predictors of ICU admission in patients with cancer and the related characteristics and outcomes: a 5-year registry-based study. Crit Care Med 44(3):548–553
Kubihal V, Chandrashekhara SH, Triveni GS (2022) Clinical imaging in oncological ICU. In: Kumar V, Gupta N, Mishra S (eds) Onco-critical care: an evidence-based approach. Springer Nature Singapore, Singapore, pp 37–50
Williams MD, Braun LA, Cooper LM, Johnston J, Weiss RV, Qualy RL et al (2004) Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care (London, England) 8(5):R291–R298
Brunet F, Lanore JJ, Dhainaut JF, Dreyfus F, Vaxelaire JF, Nouira S et al (1990) Is intensive care justified for patients with haematological malignancies? Intensive Care Med 16(5):291–297
Article CAS PubMed Google Scholar
Evison J, Ritz R, Elsasser S (2001) Intensive care unit admission in patients with hematological disease: incidence, outcome and prognostic factors. Swiss Med Wkly 131(4748):681–686
Owczuk R, Wujtewicz MA, Sawicka W, Wadrzyk A, Wujtewicz M (2005) Patients with haematological malignancies requiring invasive mechanical ventilation: differences between survivors and non-survivors in intensive care unit. Support Care Cancer: Off J Multinatl Assoc Support Care Cancer 13(5):332–338
Gordon AC, Oakervee HE, Kaya B, Thomas JM, Barnett MJ, Rohatiner AZ et al (2005) Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care. Anaesthesia 60(4):340–347
Article CAS PubMed Google Scholar
Senapati J, Dhawan R, Aggarwal M, Kumar P, Kumar Vishwanathan G, Dass J et al (2021) Venetoclax and azacitidine (VenAZA) combination therapy in young unfit patients with AML: a perspective from a developing country. Leuk Lymphoma 62(6):1514–1517
Article CAS PubMed Google Scholar
Jobanputra KN, Nayak L, Jain H, Sengar DM (2021) Diffuse large B-cell lymphoma in the elderly: retrospective analysis from a single tertiary cancer center in India. Blood 138:2515
Shaikh MRMA, Mehta P, Mirgh SP, Halder R, Agrawal N, Khushoo V et al (2021) Individualized AML induction with venetoclax based therapy in unfit treatment naïve patients aged ≤ 60 years: a real world perspective from India. Blood 138:4417
Hammond NE, Kumar A, Kaur P, Tirupakuzhi Vijayaraghavan BK, Ghosh A, Grattan S et al (2022) Estimates of sepsis prevalence and outcomes in adult patients in the ICU in India: a cross-sectional study. Chest 161(6):1543–1554
Chaudhry D, Prajapat B (2017) Intensive care unit bugs in India: How do they differ from the western world? J Assoc Chest Phys 5(1):10–17
Philip C, George B, Ganapule A, Korula A, Jain P, Alex AA et al (2015) Acute myeloid leukaemia: challenges and real world data from India. Br J Haematol 170(1):110–117
Article PubMed PubMed Central Google Scholar
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315(8):801–810
Article CAS PubMed PubMed Central Google Scholar
Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA (2019) Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int 96(5):1083–1099
Article PubMed PubMed Central Google Scholar
Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH et al (2021) KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99(3):S1–S87
Franco L, Becattini C, Beyer-Westendorf J, Vanni S, Nitti C, Re R et al (2020) Definition of major bleeding: prognostic classification. J Thromb Haemost 18(11):2852–2860
Article CAS PubMed Google Scholar
Zimmer AJ, Freifeld AG (2019) Optimal management of neutropenic fever in patients with cancer. J Oncol Pract 15(1):19–24
Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE et al (2019) Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis 71(6):1367–1376
Article PubMed Central Google Scholar
Belletti A, Lerose CC, Zangrillo A, Landoni G (2021) Vasoactive-inotropic score: evolution, clinical utility, and pitfalls. J Cardiothorac Vasc Anesth 35(10):3067–3077
Article CAS PubMed Google Scholar
Ferreyro BL, Scales DC, Wunsch H, Cheung MC, Gupta V, Saskin R et al (2021) Critical illness in patients with hematologic malignancy: a population-based cohort study. Intensive Care Med 47(10):1104–1114
de Vries VA, Müller MCA, Arbous MS, Biemond BJ, Blijlevens NMA, Kusadasi N et al (2019) Long-term outcome of patients with a hematologic malignancy and multiple organ failure admitted at the intensive care. Crit Care Med 47(2):e120–e128
Article PubMed PubMed Central Google Scholar
Tridente A, Dempsey NC, Khalifa M, Goddard J, Shuker K, Hall J et al (2023) Predicting outcomes of hematological malignancy patients admitted to critical care. Front Hematol 2. https://doi.org/10.3389/frhem.2023.1127322
Siddiqui SS, Prabu NR, Chaudhari HK, Narkhede AM, Sarode SV, Dhundi U et al (2021) Epidemiology, clinical characteristics, and prognostic factors in critically ill patients with hematolymphoid malignancy. Indian J Crit Care Med: Peer-reviewed, Off Publ Indian Soc Crit Care Med 25(1):56–61
Moreno-Sanchez F, Gomez-Gomez B (2022) Antibiotic management of patients with hematologic malignancies: from prophylaxis to unusual infections. Curr Oncol Rep 24(7):835–842
Article PubMed PubMed Central Google Scholar
Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR et al (1999) Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 25(12):1395–1401
Article CAS PubMed Google Scholar
Hampshire PA, Welch CA, McCrossan LA, Francis K, Harrison DA (2009) Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC case mix programme database. Crit Care (London, England) 13(4):R137
van Mourik N, Oomen JJ, van Vught LA, Biemond BJ, van den Bergh WM, Blijlevens NM et al (2023) The predictive value of the modified early warning score for admission to the intensive care unit in patients with a hematologic malignancy–a multicenter observational study. Intensive Crit Care Nurs 79:103486
Yoo J-W, Lee JR, Jung YK, Choi SH, Son JS, Kang BJ et al (2015) A combination of early warning score and lactate to predict intensive care unit transfer of inpatients with severe sepsis/septic shock. Korean J Intern Med 30(4):471
Article CAS PubMed PubMed Central Google Scholar
Lee JR, Jung YK, Kim HJ, Koh Y, Lim CM, Hong SB et al (2020) Derivation and validation of modified early warning score plus SpO2/FiO2 score for predicting acute deterioration of patients with hematological malignancies. Korean J Intern Med 35(6):1477–1488
Article PubMed PubMed Central Google Scholar
Mato A, Fuchs BD, Heitjan DF, Mick R, Halpern SD, Shah PD et al (2009) Utility of the systemic inflammatory response syndrome (SIRS) criteria in predicting the onset of septic shock in hospitalized patients with hematologic malignancies. Cancer Biol Ther 8(12):1095–1100
Mato AR, Luger SM, Heitjan DF, Mikkelson ME, Olson E, Ujjani C et al (2010) Elevation in serum lactate at the time of Febrile Neutropenia (FN) in hemodynamically-stable patients with Hematologic Malignancies (HM) is associated with the development of septic shock within 48 hours. Cancer Biol Ther 9(8):585–589
Article CAS PubMed Google Scholar
Nathan N, Sculier JP, Ameye L, Paesmans M, Bogdan-Dragos G, Meert AP (2021) Sepsis and septic shock definitions in patients with cancer admitted in ICU. J Intensive Care Med 36(3):255–261
Yeo CD, Kim JW, Kim SC, Kim YK, Kim KH, Kim HJ et al (2012) Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit. J Crit Care 27(6):739.e1-739.e6
Cetintepe T, Cetintepe L, Solmaz S, Calık S, Ugur MC, Gediz F et al (2021) Determination of the relationship between mortality and SOFA, qSOFA, MASCC scores in febrile neutropenic patients monitored in the intensive care unit. Support Care Cancer 29(7):4089–4094
留言 (0)